Followers | 137 |
Posts | 10050 |
Boards Moderated | 0 |
Alias Born | 04/13/2007 |
Monday, June 05, 2023 2:01:25 PM
To approve the Amended Articles of Incorporation providing for the approval of a reverse stock split of our issued and outstanding shares of Common Stock at a range of 100 to 1 and 50,000 to 1 (the “Reverse Stock Split) at the sole discretion of the Board within 24 months from the date of the Board Resolution approving the Reverse Stock Split.
The Board believes that the Reverse Stock Split will help prepare the Company to meet the listing requirements of NASDAQ, NYSE, or similar exchange that requires a minimum stock price that is currently higher than our stock price at the time of this filing. We believe that a listing on such exchange can help provide benefit to our current stockholders by improving liquidity and increasing the appeal of our stock to a larger group of retail and institutional shareholders and investors.
PLEASE NOTE THAT THE REVERSE STOCK SPLIT OPTION WILL NOT CHANGE YOUR PROPORTIONATE EQUITY INTEREST IN THE COMPANY, EXCEPT AS MAY RESULT FROM THE ISSUANCE OR CANCELLATION OF SHARES PURSUANT TO THE FRACTIONAL SHARES.
http://archive.fast-edgar.com/20230605/AW2YH22CZM2RQ2V2222922Y2KGJQZZ226252/
Recent WDLF News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:26:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:03:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:57:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 12:50:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 02:00:10 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/08/2023 06:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:41:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 10:05:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:52:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 01:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 06:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 09:25:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 12:00:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/14/2023 08:57:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:39:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM